Needham Maintains Buy on Veracyte, Raises Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Veracyte (NASDAQ:VCYT) and raises the price target from $27 to $31.
August 07, 2024 | 10:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a Buy rating on Veracyte and raises the price target from $27 to $31.
The raised price target and maintained Buy rating from a reputable analyst are likely to positively influence investor sentiment and drive short-term price appreciation for Veracyte.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100